Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 26023 | 265 | 42.4 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 62 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 86105 |
| 938 | 2 | CARDIAC HYPERTROPHY//HYPERTROPHY//CARDIOTROPHIN 1 | 10977 |
| 26023 | 1 | 3 4 DIHYDROXY L PHENYL ALANINE//4 HYDROXYNNONENAL//5 HT2B SEROTONIN RECEPTOR AGONIST | 265 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | 3 4 DIHYDROXY L PHENYL ALANINE | authKW | 115228 | 0% | 100% | 1 |
| 2 | 4 HYDROXYNNONENAL | authKW | 115228 | 0% | 100% | 1 |
| 3 | 5 HT2B SEROTONIN RECEPTOR AGONIST | authKW | 115228 | 0% | 100% | 1 |
| 4 | 8 HYDROXY 2DESOXYGUANOSINE | authKW | 115228 | 0% | 100% | 1 |
| 5 | CHAIR CARDIOVASC SCI | address | 115228 | 0% | 100% | 1 |
| 6 | CHRONIC HEART FAILURE BIOMARKERS | authKW | 115228 | 0% | 100% | 1 |
| 7 | CHU TOULOUSEIFR31 | address | 115228 | 0% | 100% | 1 |
| 8 | CIENCIAS QUIM FARAMCEUT | address | 115228 | 0% | 100% | 1 |
| 9 | DIABETES AND CARDIAC HYPERTROPHY | authKW | 115228 | 0% | 100% | 1 |
| 10 | EXPERIMENTAL ENDOTHELIAL DYSFUNCTION | authKW | 115228 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 3650 | 46% | 0% | 122 |
| 2 | Peripheral Vascular Diseases | 524 | 14% | 0% | 36 |
| 3 | Cell Biology | 143 | 14% | 0% | 36 |
| 4 | Medicine, Research & Experimental | 70 | 7% | 0% | 19 |
| 5 | Physiology | 49 | 6% | 0% | 15 |
| 6 | Endocrinology & Metabolism | 41 | 6% | 0% | 16 |
| 7 | Biochemistry & Molecular Biology | 34 | 14% | 0% | 37 |
| 8 | Pharmacology & Pharmacy | 28 | 9% | 0% | 23 |
| 9 | Hematology | 19 | 3% | 0% | 9 |
| 10 | Medicine, General & Internal | 15 | 5% | 0% | 14 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CHAIR CARDIOVASC SCI | 115228 | 0% | 100% | 1 |
| 2 | CHU TOULOUSEIFR31 | 115228 | 0% | 100% | 1 |
| 3 | CIENCIAS QUIM FARAMCEUT | 115228 | 0% | 100% | 1 |
| 4 | FED RECH CMV | 115228 | 0% | 100% | 1 |
| 5 | FEDERAT RECH MUSCLE COEUR VAISSEAUX 14 | 115228 | 0% | 100% | 1 |
| 6 | GEN MED DIAGNOST | 115228 | 0% | 100% | 1 |
| 7 | HEMATOL CHEM | 115228 | 0% | 100% | 1 |
| 8 | HERZGEFASSZENTRUM | 115228 | 0% | 100% | 1 |
| 9 | IFR 150 CARDIAC REMODELING | 115228 | 0% | 100% | 1 |
| 10 | IFR 150 TRI PLATEFORM | 115228 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANTIOXIDANTS & REDOX SIGNALING | 3019 | 3% | 0% | 9 |
| 2 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2137 | 4% | 0% | 11 |
| 3 | EXPERIMENTAL & CLINICAL CARDIOLOGY | 1818 | 1% | 1% | 2 |
| 4 | EUROPEAN REVIEW OF AGING AND PHYSICAL ACTIVITY | 983 | 0% | 1% | 1 |
| 5 | REDOX BIOLOGY | 968 | 1% | 0% | 2 |
| 6 | CIRCULATION RESEARCH | 913 | 3% | 0% | 9 |
| 7 | HELLENIC JOURNAL OF CARDIOLOGY | 877 | 1% | 0% | 2 |
| 8 | APOPTOSIS | 852 | 0% | 1% | 1 |
| 9 | JOURNAL OF APPLIED CARDIOLOGY | 798 | 0% | 1% | 1 |
| 10 | EUROPEAN JOURNAL OF HEART FAILURE | 776 | 2% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LAIREZ, O , COGNET, T , SCHAAK, S , CALISE, D , GUILBEAU-FRUGIER, C , PARINI, A , MIALET-PEREZ, J , (2013) ROLE OF SEROTONIN 5-HT2A RECEPTORS IN THE DEVELOPMENT OF CARDIAC HYPERTROPHY IN RESPONSE TO AORTIC CONSTRICTION IN MICE.JOURNAL OF NEURAL TRANSMISSION. VOL. 120. ISSUE 6. P. 927-935 | 12 | 48% | 9 |
| 2 | KARABACAK, M , DOGAN, A , TAYYAR, S , BAS, HA , (2014) OXIDATIVE STRESS STATUS INCREASE IN PATIENTS WITH NONISCHEMIC HEART FAILURE.MEDICAL PRINCIPLES AND PRACTICE. VOL. 23. ISSUE 6. P. 532 -537 | 11 | 48% | 2 |
| 3 | TSUTSUI, H , KINUGAWA, S , MATSUSHIMA, S , (2011) OXIDATIVE STRESS AND HEART FAILURE.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 301. ISSUE 6. P. H2181-H2190 | 19 | 17% | 215 |
| 4 | QIN, FZ , LENNON-EDWARDS, S , LANCEL, S , BIOLO, A , SIWIK, DA , PIMENTEL, DR , DORN, GW , KANG, YJ , COLUCCI, WS , (2010) CARDIAC-SPECIFIC OVEREXPRESSION OF CATALASE IDENTIFIES HYDROGEN PEROXIDE-DEPENDENT AND -INDEPENDENT PHASES OF MYOCARDIAL REMODELING AND PREVENTS THE PROGRESSION TO OVERT HEART FAILURE IN G ALPHA Q-OVEREXPRESSING TRANSGENIC MICE.CIRCULATION-HEART FAILURE. VOL. 3. ISSUE 2. P. 306-313 | 13 | 38% | 15 |
| 5 | BAI, CF , LIU, JC , ZHAO, R , CAO, W , LIU, SB , ZHANG, XN , GUO, HJ , YANG, Q , YI, DH , ZHAO, MG , (2010) ROLE OF 5-HT2B RECEPTORS IN CARDIOMYOCYTE APOPTOSIS IN NORADRENALINE-INDUCED CARDIOMYOPATHY IN RATS.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 37. ISSUE 7. P. E145 -E151 | 13 | 39% | 5 |
| 6 | CAMPOLO, J , DE MARIA, R , CARUSO, R , ACCINNI, R , TURAZZA, F , PAROLINI, M , ROUBINA, E , DE CHIARA, B , CIGHETTI, G , FRIGERIO, M , ET AL (2007) BLOOD GLUTATHIONE AS INDEPENDENT MARKER OF LIPID PEROXIDATION IN HEART FAILURE.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 117. ISSUE 1. P. 45-50 | 12 | 41% | 14 |
| 7 | KRUPA, W , ROZWODOWSKA, M , SIELSKI, S , CZARNECKA-ZABA, E , FABISZAK, T , DREWA, G , KASPRZAK, M , KUBICA, J , (2014) INFLUENCE OF CARDIAC RESYNCHRONIZATION THERAPY ON OXIDATIVE STRESS MARKERS IN PATIENTS WITH CHRONIC HEART FAILURE.CARDIOLOGY JOURNAL. VOL. 21. ISSUE 5. P. 576 -582 | 10 | 38% | 1 |
| 8 | KORANTZOPOULOS, P , VLACHOU, C , KOTSIA, A , KALANTZI, K , BARBOUTI, A , GALARIS, D , GOUDEVENOS, JA , (2012) LEUKOCYTE LABILE IRON POOL IN PATIENTS WITH SYSTOLIC HEART FAILURE.HELLENIC JOURNAL OF CARDIOLOGY. VOL. 53. ISSUE 2. P. 95-100 | 10 | 38% | 2 |
| 9 | RADOVANOVIC, S , SAVIC-RADOJEVIC, A , PLJESA-ERCEGOVAC, M , DJUKIC, T , SUVAKOV, S , KROTIN, M , SIMIC, DV , MATIC, M , RADOJICIC, Z , PEKMEZOVIC, T , ET AL (2012) MARKERS OF OXIDATIVE DAMAGE AND ANTIOXIDANT ENZYME ACTIVITIES AS PREDICTORS OF MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEART FAILURE.JOURNAL OF CARDIAC FAILURE. VOL. 18. ISSUE 6. P. 493 -501 | 11 | 32% | 11 |
| 10 | TSUTSUI, H , (2001) OXIDATIVE STRESS IN HEART FAILURE: THE ROLE OF MITOCHONDRIA.INTERNAL MEDICINE. VOL. 40. ISSUE 12. P. 1177-1182 | 11 | 42% | 41 |
Classes with closest relation at Level 1 |